{"nct_id":"NCT04007198","title":"A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2019-06-20","start_date_type":"ACTUAL","primary_completion_date":"2021-10-12","primary_completion_date_type":"ACTUAL","completion_date":"2021-10-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["EQ"]}